In our study we have also characterized the malignant phenotype of the OSA3-CSCs by the analysis of the activity and the expression of aldehyde dehydrogenase 1 family, member A1 (ALDH1A1) a detoxification enzyme, which is responsible for the tumor resistance to cytotoxic chemotherapy [55]. This evidence concerns the gene ALDH1A1 and neoplasm.